Showing results (2121-2130 of 3,188) with videos related to

Sort By:
Pageof 319
Plos One|August 12, 2016
Multivitamin Use and Serum Vitamin B12 Concentrations in Older-Adult Metformin Users in REGARDS, 2003-2007Vijaya Kancherla, Joshua V Garn, Neil A Zakai, et al.
World Journal of Gastroenterology|March 22, 2007
Hepatitis C risk assessment, testing and referral for treatment in urban primary care: role of race and ethnicityStacey B Trooskin, Victor J Navarro, Robert J Winn, et al.
Orbit (Amsterdam, Netherlands)|August 3, 2022
Augmentation of telemedicine post-operative follow-up after oculofacial plastic surgery with a self-guided patient toolDavin C Ashraf, Amanda Miller, Meleha Ahmad, et al.
Clinical Kidney Journal|September 29, 2015
Variability in phenotype induced by the podocin variant R229Q plus a single pathogenic mutationPaul J Phelan, Gentzon Hall, Delbert Wigfall, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1994
Phase II trial of edatrexate in patients with advanced hepatocellular carcinomaR Pazdur, D F Moore, B Bready, et al.
The Journal of Biological Chemistry|February 13, 2002
Inhibition of protein geranylgeranylation and RhoA/RhoA kinase pathway induces apoptosis in human endothelial cellsXianwu Li, Li Liu, Joan C Tupper, et al.
Journal of Neurosurgery|October 20, 2009
Association of a younger age with an increased risk of angiographic and symptomatic vasospasms following subarachnoid hemorrhageSuresh N Magge, H Isaac Chen, Rohan Ramakrishna, et al.
The Journal of Clinical Investigation|April 7, 2015
Gq signaling causes glomerular injury by activating TRPC6Liming Wang, Grant Jirka, Paul B Rosenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1990
Phase II study of fluorouracil and recombinant interferon alfa-2a in previously untreated advanced colorectal carcinomaR Pazdur, J A Ajani, Y Z Patt, et al.
Anti-Cancer Drugs|July 8, 2000
Phase II trial of 5-fluorouracil, folinic acid and recombinant alpha-2a-interferon in patients with advanced colorectal cancerF Ravandi, M E Rytting, C Osmon, et al.
Pageof 319